Tumor Necrosis Factor Blocker [EPC]

Tumor Necrosis Factor Blocker [EPC] was reported 999331 times

Drugs of the Tumor Necrosis Factor Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INJECTION SITE RECALL REACTION 487 0.9644
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 6357 0.8864
2 RHEUMATOID FACTOR POSITIVE 4933 0.8532
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 562 0.8413
4 SWOLLEN JOINT COUNT INCREASED 2608 0.8170
5 RHEUMATIC FEVER 3633 0.8142
6 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1872 0.8118
7 LUPUS VULGARIS 1006 0.7984
8 PEMPHIGUS 9785 0.7819
9 C-REACTIVE PROTEIN ABNORMAL 4896 0.7625
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 1509 0.7534
11 HAND DEFORMITY 9759 0.7433
12 SYNOVITIS 13187 0.7306
13 C-REACTIVE PROTEIN 676 0.7292
14 DUODENAL ULCER PERFORATION 5336 0.7168
15 FACET JOINT SYNDROME 2256 0.6922
16 AXIAL SPONDYLOARTHRITIS 607 0.6906
17 INJECTION SITE MACULE 472 0.6891
18 GRANULOMA SKIN 549 0.6687
19 DRUG SPECIFIC ANTIBODY 865 0.6314
20 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1287 0.6205
21 BONE EROSION 2181 0.6161
22 JOINT DESTRUCTION 951 0.6112
23 DISLOCATION OF VERTEBRA 1375 0.6023
24 X-RAY ABNORMAL 1072 0.5989
25 JUVENILE IDIOPATHIC ARTHRITIS 1425 0.5821
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3721 0.5724
27 MUSCLE INJURY 4730 0.5703
28 HELICOBACTER INFECTION 5829 0.5666
29 COVID-19 IMMUNISATION 470 0.5629
30 ANKYLOSING SPONDYLITIS 7309 0.5540
31 FOLLICULITIS 5797 0.5523
32 RETINITIS 952 0.5506
33 FAECAL CALPROTECTIN INCREASED 1741 0.5492
34 RHEUMATOID ARTHRITIS 62163 0.5470
35 RHEUMATOID NODULE 1468 0.5325
36 INJECTION SITE WARMTH 10605 0.5151
37 LUPUS-LIKE SYNDROME 4513 0.4971
38 ENTHESOPATHY 762 0.4869
39 SERONEGATIVE ARTHRITIS 550 0.4799
40 CONTRAINDICATED PRODUCT ADMINISTERED 14423 0.4759
41 DRUG LEVEL BELOW THERAPEUTIC 2614 0.4734
42 FINGER DEFORMITY 2204 0.4545
43 PERIPHERAL VENOUS DISEASE 1838 0.4496
44 PERICARDITIS 7455 0.4433
45 PSORIATIC ARTHROPATHY 17488 0.4304
46 INJECTION SITE HAEMATOMA 6248 0.4302
47 DISSEMINATED TUBERCULOSIS 1088 0.4237
48 DRUG SPECIFIC ANTIBODY PRESENT 2745 0.4217
49 BLOOD PARATHYROID HORMONE DECREASED 622 0.4194
50 GLOSSODYNIA 9380 0.4185
51 RHEUMATOID LUNG 394 0.4126
52 SINUSITIS BACTERIAL 426 0.4042
53 BLOOD IRON ABNORMAL 390 0.3992
54 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4419 0.3990
55 GRIP STRENGTH DECREASED 3511 0.3985
56 ANAL FISSURE 2125 0.3958
57 DRUG TOLERANCE DECREASED 1108 0.3942
58 DACTYLITIS 382 0.3890
59 PYODERMA GANGRENOSUM 1389 0.3857
60 SYSTEMIC LUPUS ERYTHEMATOSUS 13584 0.3823
61 JOINT ARTHROPLASTY 683 0.3811
62 PUSTULAR PSORIASIS 1302 0.3787
63 INTESTINAL RESECTION 1891 0.3513
64 JOINT RANGE OF MOTION DECREASED 4679 0.3485
65 INJECTION SITE ERYTHEMA 42491 0.3422
66 WOUND 9533 0.3407
67 INJECTION SITE PRURITUS 22792 0.3399
68 SACROILIITIS 635 0.3362
69 PANNICULITIS 812 0.3353
70 INJECTION SITE REACTION 22358 0.3246
71 TUBERCULIN TEST POSITIVE 820 0.3236
72 TENOSYNOVITIS 886 0.3209
73 INJECTION SITE SWELLING 24477 0.3191
74 INFUSION RELATED REACTION 20968 0.3160
75 PULMONARY TUBERCULOSIS 1347 0.3150
76 HISTOPLASMOSIS DISSEMINATED 499 0.3142
77 BURSITIS 3802 0.3131
78 INJECTION SITE INDURATION 4051 0.3122
79 HISTOPLASMOSIS 550 0.3104
80 ILEAL STENOSIS 549 0.3086
81 ONYCHOMADESIS 1292 0.3075
82 ARTHROPATHY 17013 0.3058
83 UVEITIS 4095 0.3016
84 CROHN'S DISEASE 2065 0.3010
85 ANAL FISTULA 1606 0.3007
86 THERAPEUTIC PRODUCT EFFECT DECREASED 13414 0.2992
87 INJECTION SITE DISCOLOURATION 3736 0.2987
88 BREAST CANCER STAGE III 1936 0.2986
89 DEMYELINATION 1223 0.2981
90 WOUND INFECTION 3263 0.2977
91 FOOT DEFORMITY 3269 0.2946
92 FISTULA 3315 0.2946
93 ONYCHOMYCOSIS 1292 0.2942
94 LATENT TUBERCULOSIS 616 0.2939
95 DRUG LEVEL DECREASED 2963 0.2908
96 ERYTHEMA NODOSUM 1016 0.2891
97 ANTIBODY TEST POSITIVE 476 0.2866
98 ANAL ABSCESS 1539 0.2853
99 IRITIS 867 0.2849
100 POLYARTHRITIS 1494 0.2831
101 EXPOSURE TO SARS-COV-2 481 0.2828
102 LOWER RESPIRATORY TRACT INFECTION 12780 0.2807
103 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 664 0.2796
104 DRUG LEVEL ABOVE THERAPEUTIC 1272 0.2774
105 SCLERITIS 444 0.2770
106 IRRITABLE BOWEL SYNDROME 5943 0.2769
107 FIBROMYALGIA 6689 0.2749
108 PNEUMONIA LEGIONELLA 440 0.2747
109 INJECTION SITE IRRITATION 3485 0.2735
110 COLECTOMY 1537 0.2718
111 MATERNAL EXPOSURE BEFORE PREGNANCY 1855 0.2713
112 PORPHYRIA ACUTE 388 0.2704
113 KNEE ARTHROPLASTY 5633 0.2673
114 JOINT SWELLING 31280 0.2589
115 LIP DRY 2353 0.2588
116 IMPAIRED HEALING 8502 0.2587
117 TRANSPLANT DYSFUNCTION 462 0.2587
118 PSORIASIS 33410 0.2555
119 RECTAL ABSCESS 424 0.2525
120 INTESTINAL STENOSIS 1065 0.2523
121 HIP ARTHROPLASTY 3862 0.2519
122 SHOULDER ARTHROPLASTY 676 0.2507
123 INJECTION SITE RASH 7693 0.2505
124 DERMATITIS PSORIASIFORM 511 0.2499
125 JOINT STIFFNESS 6526 0.2485
126 HYPERCHOLESTEROLAEMIA 2387 0.2470
127 INTENTIONAL PRODUCT USE ISSUE 21567 0.2459
128 JOINT EFFUSION 1682 0.2437
129 FEMALE GENITAL TRACT FISTULA 415 0.2428
130 ILEOSTOMY 610 0.2387
131 DRUG EFFECT INCOMPLETE 8636 0.2375
132 FOOT OPERATION 1162 0.2346
133 SKIN PLAQUE 1960 0.2321
134 INJECTION SITE URTICARIA 5579 0.2272
135 MATERNAL EXPOSURE DURING BREAST FEEDING 917 0.2258
136 BODY TEMPERATURE FLUCTUATION 469 0.2249
137 PARANASAL SINUS HYPERSECRETION 850 0.2225
138 PNEUMOCYSTIS JIROVECI PNEUMONIA 493 0.2211
139 NAIL DISORDER 1926 0.2199
140 APHTHOUS ULCER 1703 0.2193
141 ANTINUCLEAR ANTIBODY POSITIVE 712 0.2189
142 MUSCULOSKELETAL STIFFNESS 18836 0.2148
143 DRUG INTOLERANCE 20755 0.2146
144 TREATMENT FAILURE 17678 0.2132
145 SINUSITIS 21831 0.2128
146 EXOSTOSIS 1942 0.2124
147 INCORRECT PRODUCT STORAGE 2775 0.2110
148 LARGE INTESTINAL STENOSIS 421 0.2104
149 BLEPHAROSPASM 1323 0.2099
150 CHONDROPATHY 569 0.2099
151 C-REACTIVE PROTEIN INCREASED 7638 0.2097
152 AUTOIMMUNE DISORDER 2036 0.2087
153 JOINT LOCK 593 0.2087
154 BLOOD PRESSURE FLUCTUATION 4987 0.2076
155 PROCTITIS 576 0.2054
156 COLITIS ULCERATIVE 9112 0.2037
157 LIVE BIRTH 1701 0.2031
158 ABSCESS 3242 0.2030
159 NODULE 2636 0.2018
160 LOCAL SWELLING 3519 0.2015
161 BASAL CELL CARCINOMA 3143 0.2013
162 LOSS OF THERAPEUTIC RESPONSE 639 0.2003
163 INJECTION SITE PAIN 61024 0.1987
164 FEAR OF INJECTION 1415 0.1982
165 TONSILLITIS 1034 0.1979
166 ARTHRITIS BACTERIAL 808 0.1967
167 PULMONARY FIBROSIS 3771 0.1964
168 PHARYNGITIS STREPTOCOCCAL 2125 0.1961
169 OSTEOARTHRITIS 8272 0.1949
170 SARCOIDOSIS 926 0.1947
171 DENGUE FEVER 446 0.1943
172 SYNOVIAL CYST 895 0.1936
173 INFLAMMATION 9987 0.1933
174 TOOTH INFECTION 2550 0.1932
175 IRIDOCYCLITIS 607 0.1919
176 INJECTION SITE BRUISING 15191 0.1902
177 MUSCULOSKELETAL PAIN 9923 0.1892
178 MOBILITY DECREASED 13521 0.1880
179 MUCOUS STOOLS 929 0.1874
180 SCIATICA 2977 0.1866
181 INJECTION SITE HYPERSENSITIVITY 582 0.1859
182 INJECTION SITE DISCOMFORT 1955 0.1857
183 POOR VENOUS ACCESS 1911 0.1845
184 ARTHRITIS INFECTIVE 849 0.1829
185 SPONDYLITIS 665 0.1827
186 WALKING AID USER 1192 0.1806
187 POST PROCEDURAL INFECTION 1467 0.1802
188 DECREASED IMMUNE RESPONSIVENESS 1756 0.1788
189 SPINAL FUSION SURGERY 724 0.1783
190 HEPATIC ENZYME INCREASED 12009 0.1760
191 INJECTION SITE INFLAMMATION 875 0.1755
192 EAR INFECTION 4670 0.1753
193 SWELLING 16384 0.1749
194 DRUG EFFECT DECREASED 9396 0.1743
195 BLOOD PRESSURE DIASTOLIC INCREASED 803 0.1738
196 PHARYNGITIS 2154 0.1735
197 INFECTIOUS MONONUCLEOSIS 389 0.1734
198 RESPIRATORY TRACT CONGESTION 2741 0.1723
199 LYMPHOPROLIFERATIVE DISORDER 504 0.1714
200 OBESITY 2719 0.1705
201 ARTHRITIS 13350 0.1695
202 STREPTOCOCCAL INFECTION 944 0.1695
203 TOOTH ABSCESS 1713 0.1681
204 FREQUENT BOWEL MOVEMENTS 4513 0.1669
205 ARTHROPOD BITE 1237 0.1668
206 THERAPEUTIC RESPONSE DECREASED 10090 0.1662
207 BRONCHITIS CHRONIC 405 0.1657
208 INFUSION SITE REACTION 492 0.1645
209 ENDODONTIC PROCEDURE 415 0.1635
210 JOINT DISLOCATION 1728 0.1633
211 ARTHRALGIA 67848 0.1630
212 B-CELL LYMPHOMA 553 0.1626
213 LIVER INJURY 3991 0.1624
214 SINUS CONGESTION 2185 0.1616
215 NASOPHARYNGITIS 29694 0.1609
216 SERUM SICKNESS 448 0.1606
217 LIMB OPERATION 770 0.1603
218 LYMPHOMA 2460 0.1590
219 ANIMAL BITE 424 0.1590
220 BLOOD PRESSURE DIASTOLIC DECREASED 1174 0.1589
221 FURUNCLE 1252 0.1578
222 INJECTION SITE VESICLES 955 0.1576
223 HERPES ZOSTER 9041 0.1572
224 LYME DISEASE 521 0.1561
225 SUSPECTED OFF LABEL USE 706 0.1561
226 IMMUNOSUPPRESSION 1372 0.1554
227 LOCALISED INFECTION 3723 0.1538
228 SUBCUTANEOUS ABSCESS 734 0.1530
229 VIRAL UPPER RESPIRATORY TRACT INFECTION 726 0.1526
230 CONDITION AGGRAVATED 46284 0.1521
231 DEVICE DEPLOYMENT ISSUE 1944 0.1520
232 MATERNAL EXPOSURE DURING PREGNANCY 13558 0.1520
233 MATERNAL EXPOSURE TIMING UNSPECIFIED 571 0.1519
234 BACK INJURY 1651 0.1517
235 SENSITIVITY TO WEATHER CHANGE 797 0.1513
236 ADVERSE REACTION 2004 0.1510
237 SINUS HEADACHE 884 0.1486
238 MALIGNANT MELANOMA 1983 0.1479
239 TYPE 2 DIABETES MELLITUS 4983 0.1479
240 UPPER RESPIRATORY TRACT INFECTION 6837 0.1478
241 FINE MOTOR SKILL DYSFUNCTION 428 0.1477
242 INFECTION 21379 0.1476
243 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7071 0.1471
244 LOWER LIMB FRACTURE 2826 0.1469
245 COELIAC DISEASE 1427 0.1453
246 INTENTIONAL DOSE OMISSION 4144 0.1452
247 VULVOVAGINAL MYCOTIC INFECTION 569 0.1445
248 GAIT INABILITY 4822 0.1441
249 EAR PAIN 2789 0.1433
250 KNEE OPERATION 1405 0.1427
251 HIP SURGERY 773 0.1427
252 MUSCULOSKELETAL DISORDER 2702 0.1418
253 LIVER FUNCTION TEST INCREASED 3032 0.1411
254 INFLAMMATORY MARKER INCREASED 700 0.1411
255 DISCOMFORT 8597 0.1408
256 INJECTION SITE EXTRAVASATION 1733 0.1403
257 POSTOPERATIVE WOUND INFECTION 947 0.1401
258 SKIN PAPILLOMA 557 0.1388
259 THYROID NEOPLASM 382 0.1384
260 THERAPEUTIC RESPONSE SHORTENED 4585 0.1381
261 ABSCESS LIMB 589 0.1381
262 INFUSION SITE EXTRAVASATION 852 0.1367
263 BLISTER 7679 0.1366
264 CHRONIC SINUSITIS 511 0.1360
265 BRONCHITIS 10066 0.1359
266 THERAPY NON-RESPONDER 6105 0.1357
267 SKIN INFECTION 1506 0.1341
268 NIGHT SWEATS 4314 0.1338
269 HAEMATOCHEZIA 7383 0.1336
270 BODY TEMPERATURE DECREASED 1316 0.1335
271 INCORRECT DRUG ADMINISTRATION RATE 568 0.1333
272 GRANULOMA 461 0.1330
273 CLOSTRIDIUM DIFFICILE INFECTION 2892 0.1324
274 SQUAMOUS CELL CARCINOMA 1247 0.1323
275 INCREASED TENDENCY TO BRUISE 1214 0.1318
276 SHOULDER OPERATION 561 0.1311
277 LACERATION 1227 0.1303
278 ABDOMINAL ABSCESS 575 0.1300
279 WHEELCHAIR USER 576 0.1294
280 HIDRADENITIS 1179 0.1291
281 SUSPECTED COVID-19 425 0.1287
282 DIVERTICULITIS 3562 0.1284
283 CYST 1595 0.1284
284 SKIN NECROSIS 666 0.1282
285 DEFAECATION URGENCY 894 0.1275
286 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9041 0.1270
287 BRONCHIECTASIS 848 0.1257
288 SURGERY 7353 0.1253
289 PERIPHERAL SWELLING 19256 0.1249
290 INJECTION SITE HAEMORRHAGE 9974 0.1248
291 DIARRHOEA HAEMORRHAGIC 1165 0.1245
292 SPINAL PAIN 1456 0.1241
293 KIDNEY INFECTION 2428 0.1236
294 THERAPY INTERRUPTED 8842 0.1236
295 IMMUNODEFICIENCY 1844 0.1236
296 APPARENT DEATH 444 0.1232
297 DRUG TOLERANCE 623 0.1230
298 TENDERNESS 1283 0.1230
299 SKIN CANCER 2648 0.1229
300 INFLUENZA 13698 0.1227
301 IMMUNE SYSTEM DISORDER 1583 0.1200
302 PHARYNGOLARYNGEAL PAIN 635 0.1194
303 INSURANCE ISSUE 1824 0.1192
304 GALLBLADDER OPERATION 482 0.1190
305 STOMATITIS 7221 0.1189
306 GASTROINTESTINAL INFLAMMATION 931 0.1187
307 PRODUCT LABEL CONFUSION 691 0.1184
308 NECK PAIN 6578 0.1176
309 GASTROINTESTINAL INFECTION 1055 0.1176
310 LUNG NEOPLASM 502 0.1174
311 EYE INFECTION 1327 0.1174
312 HERPES VIRUS INFECTION 674 0.1169
313 PRESCRIBED OVERDOSE 2264 0.1169
314 STAPHYLOCOCCAL INFECTION 3838 0.1162
315 ORAL INFECTION 452 0.1155
316 BLOOD CHOLESTEROL INCREASED 5389 0.1155
317 JOINT INJURY 2465 0.1153
318 INFLAMMATORY BOWEL DISEASE 1126 0.1150
319 HYSTERECTOMY 987 0.1138
320 VAGINAL INFECTION 532 0.1129
321 PAIN IN EXTREMITY 33298 0.1129
322 SKIN ULCER 2921 0.1129
323 OROPHARYNGEAL PAIN 10453 0.1128
324 RHINITIS 898 0.1113
325 ERYSIPELAS 555 0.1103
326 ULCER 1749 0.1098
327 FUNGAL SKIN INFECTION 443 0.1096
328 CUTANEOUS VASCULITIS 400 0.1095
329 CARPAL TUNNEL SYNDROME 1533 0.1094
330 HEPATIC ENZYME ABNORMAL 544 0.1090
331 CELLULITIS 5492 0.1089
332 IMMOBILE 475 0.1087
333 MOUTH ULCERATION 2285 0.1083
334 HYPERSENSITIVITY 20111 0.1082
335 CONTUSION 10418 0.1081
336 PLEURISY 642 0.1080
337 HEART RATE DECREASED 3781 0.1076
338 INCREASED UPPER AIRWAY SECRETION 551 0.1072
339 INJECTION SITE MASS 3961 0.1070
340 INTERCEPTED PRODUCT ADMINISTRATION ERROR 821 0.1070
341 ILL-DEFINED DISORDER 6457 0.1062
342 MELANOCYTIC NAEVUS 463 0.1055
343 ORAL HERPES 2056 0.1052
344 LUNG DISORDER 5157 0.1051
345 EXPOSURE VIA BREAST MILK 419 0.1051
346 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18946 0.1050
347 NEPHROLITHIASIS 4821 0.1050
348 WEIGHT FLUCTUATION 1098 0.1048
349 PULMONARY MASS 1556 0.1044
350 OVARIAN CYST 1043 0.1042
351 SPINAL COLUMN STENOSIS 492 0.1041
352 HEPATIC CIRRHOSIS 1951 0.1037
353 DRUG EFFECT DELAYED 468 0.1031
354 ULCER HAEMORRHAGE 697 0.1029
355 RASH VESICULAR 498 0.1029
356 BLOOD PRESSURE SYSTOLIC INCREASED 1997 0.1023
357 RESPIRATORY TRACT INFECTION 2662 0.1021
358 GASTROINTESTINAL DISORDER 9128 0.1018
359 COLITIS MICROSCOPIC 480 0.1012
360 MASS 1415 0.1011
361 PRODUCT USE ISSUE 18996 0.1010
362 SPINAL OPERATION 1245 0.1010
363 MENISCUS INJURY 621 0.1009
364 PAIN 61979 0.1008
365 CYSTITIS 3211 0.1007
366 CAESAREAN SECTION 1171 0.1005
367 GASTROENTERITIS VIRAL 1812 0.1003
368 SPINAL DISORDER 950 0.1002
369 SECRETION DISCHARGE 1255 0.1001
370 ABDOMINAL DISCOMFORT 16794 0.1000
371 PROCTALGIA 640 0.0994
372 NO THERAPEUTIC RESPONSE 1208 0.0990
373 BODY TEMPERATURE INCREASED 2017 0.0988
374 RASH PUSTULAR 719 0.0986
375 SPINAL STENOSIS 405 0.0980
376 ALOPECIA 19265 0.0980
377 DISABILITY 1938 0.0979
378 LIVER DISORDER 4330 0.0975
379 ENDOMETRIOSIS 461 0.0966
380 LIGAMENT RUPTURE 420 0.0950
381 NASAL CONGESTION 5586 0.0950
382 FOOD ALLERGY 733 0.0949
383 RHINORRHOEA 6121 0.0946
384 INTERVERTEBRAL DISC PROTRUSION 2053 0.0938
385 VIRAL INFECTION 3124 0.0938
386 VASCULITIS 1093 0.0937
387 ROAD TRAFFIC ACCIDENT 3887 0.0928
388 OFF LABEL USE 81282 0.0927
389 SKIN MASS 619 0.0926
390 DEVICE FAILURE 1399 0.0918
391 EYE OPERATION 423 0.0917
392 DRUG DOSE OMISSION 15151 0.0916
393 DRUG DELIVERY SYSTEM MALFUNCTION 468 0.0915
394 GESTATIONAL DIABETES 435 0.0912
395 IRON DEFICIENCY 410 0.0911
396 ORAL CANDIDIASIS 1195 0.0907
397 PURULENT DISCHARGE 387 0.0905
398 SKIN LESION 2483 0.0904
399 NEEDLE ISSUE 2629 0.0902
400 TOOTH FRACTURE 995 0.0902
401 DRUG INEFFECTIVE 118444 0.0898
402 TOOTH EXTRACTION 1118 0.0897
403 MUSCULOSKELETAL DISCOMFORT 1522 0.0883
404 UMBILICAL HERNIA 413 0.0883
405 LYMPHADENOPATHY 3115 0.0879
406 ACCIDENTAL EXPOSURE TO PRODUCT 9047 0.0877
407 CATARACT OPERATION 520 0.0875
408 COLITIS 3313 0.0873
409 INTERVERTEBRAL DISC DEGENERATION 802 0.0866
410 ROTATOR CUFF SYNDROME 1113 0.0866
411 DEFORMITY 810 0.0866
412 PREGNANCY 1732 0.0864
413 FUNGAL INFECTION 2875 0.0862
414 LUNG INFECTION 1340 0.0862
415 GINGIVITIS 465 0.0861
416 SPUTUM DISCOLOURED 817 0.0861
417 PRURITUS GENERALISED 1858 0.0858
418 PYELONEPHRITIS 740 0.0853
419 EXPOSURE DURING PREGNANCY 5302 0.0852
420 RASH PRURITIC 4622 0.0852
421 FOETAL DEATH 442 0.0851
422 HEPATIC STEATOSIS 1586 0.0851
423 TOOTHACHE 1541 0.0850
424 SINUS DISORDER 1685 0.0850
425 OSTEOPOROSIS 3491 0.0848
426 PREMATURE LABOUR 479 0.0846
427 HEART RATE IRREGULAR 1908 0.0844
428 DRUG ERUPTION 1491 0.0841
429 SKIN LACERATION 912 0.0838
430 BREAST CANCER STAGE II 696 0.0836
431 RECTAL HAEMORRHAGE 3580 0.0832
432 WEIGHT INCREASED 18653 0.0832
433 FOOD POISONING 444 0.0828
434 PRODUCT AVAILABILITY ISSUE 1885 0.0827
435 GENERAL PHYSICAL HEALTH DETERIORATION 9547 0.0824
436 ENTERITIS 526 0.0821
437 RESPIRATORY DISORDER 2457 0.0820
438 PRESCRIBED UNDERDOSE 1635 0.0819
439 OSTEOMYELITIS 1484 0.0819
440 PNEUMOCYSTIS JIROVECII PNEUMONIA 813 0.0809
441 HEPATITIS 2071 0.0809
442 SKIN REACTION 1137 0.0806
443 TOOTH DISORDER 1794 0.0806
444 PRODUCT DISTRIBUTION ISSUE 747 0.0805
445 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2705 0.0800
446 ACCIDENT 954 0.0798
447 BREAST MASS 536 0.0797
448 HYPOAESTHESIA 11900 0.0794
449 NERVE COMPRESSION 733 0.0793
450 DEVICE ISSUE 7114 0.0792
451 URTICARIA 13284 0.0792
452 SPINAL OSTEOARTHRITIS 696 0.0791
453 CONGENITAL ANOMALY 611 0.0788
454 PNEUMONIA 25548 0.0788
455 FOOT FRACTURE 1494 0.0787
456 MENINGITIS 524 0.0784
457 AUTOIMMUNE HEPATITIS 545 0.0783
458 SQUAMOUS CELL CARCINOMA OF SKIN 473 0.0783
459 HYPERKERATOSIS 432 0.0782
460 BACTERIAL INFECTION 1459 0.0781
461 WHEEZING 4628 0.0780
462 BEDRIDDEN 1025 0.0779
463 BLOOD IRON DECREASED 925 0.0779
464 UNDERDOSE 5679 0.0777
465 HAND FRACTURE 549 0.0774
466 URINARY TRACT INFECTION 13193 0.0773
467 PRODUCTIVE COUGH 3692 0.0773
468 SLEEP DISORDER 5451 0.0772
469 ADRENAL INSUFFICIENCY 935 0.0770
470 VARICOSE VEIN 396 0.0766
471 LIMB INJURY 2075 0.0763
472 TENDONITIS 1177 0.0759
473 ADVERSE DRUG REACTION 6826 0.0759
474 COLON CANCER 1132 0.0759
475 UNEVALUABLE EVENT 5712 0.0754
476 SKIN WARM 438 0.0752
477 EYE INFLAMMATION 718 0.0752
478 RASH ERYTHEMATOUS 3586 0.0749
479 INGUINAL HERNIA 456 0.0749
480 MACULAR DEGENERATION 895 0.0749
481 BACK DISORDER 1217 0.0748
482 BACK PAIN 17380 0.0747
483 TENDON DISORDER 486 0.0745
484 MALAISE 32663 0.0744
485 IMPAIRED WORK ABILITY 1591 0.0744
486 EPSTEIN-BARR VIRUS INFECTION 465 0.0744
487 SCAB 847 0.0742
488 LIGAMENT SPRAIN 734 0.0742
489 APPENDICITIS 692 0.0740
490 INJURY ASSOCIATED WITH DEVICE 1508 0.0740
491 COVID-19 12966 0.0738
492 DERMATITIS ALLERGIC 929 0.0738
493 GASTROINTESTINAL PAIN 811 0.0736
494 HERNIA 1421 0.0734
495 ADVERSE EVENT 6771 0.0734
496 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 551 0.0733
497 FEELING HOT 4499 0.0733
498 SARS-COV-2 TEST POSITIVE 969 0.0733
499 LIMB DISCOMFORT 2269 0.0733
500 GASTROENTERITIS 1069 0.0732
501 SMALL INTESTINAL OBSTRUCTION 900 0.0730
502 HERPES SIMPLEX 473 0.0727
503 SKIN DISORDER 2425 0.0726
504 LIVER FUNCTION TEST ABNORMAL 2110 0.0725
505 IRON DEFICIENCY ANAEMIA 668 0.0723
506 RASH 31464 0.0721
507 INTESTINAL PERFORATION 810 0.0721
508 UPPER LIMB FRACTURE 1433 0.0719
509 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1233 0.0718
510 GENERAL SYMPTOM 539 0.0718
511 COUGH 20145 0.0718
512 GROIN PAIN 628 0.0714
513 SCRATCH 754 0.0714
514 CATARACT 4250 0.0713
515 SNEEZING 1595 0.0710
516 PYREXIA 24420 0.0705
517 MIGRAINE 6718 0.0703
518 OPTIC NEURITIS 638 0.0701
519 CHOLECYSTECTOMY 800 0.0700
520 WRIST FRACTURE 839 0.0699
521 TONGUE DISORDER 504 0.0696
522 HYPERTENSION 14740 0.0695
523 GAIT DISTURBANCE 13203 0.0689
524 PNEUMONIA BACTERIAL 633 0.0689
525 ANKLE FRACTURE 1063 0.0686
526 FAECES SOFT 499 0.0685
527 INTESTINAL OBSTRUCTION 2586 0.0685
528 GINGIVAL PAIN 546 0.0685
529 ABDOMINAL PAIN 15906 0.0683
530 NEOPLASM 785 0.0682
531 PRODUCT STORAGE ERROR 5952 0.0679
532 MYOSITIS 609 0.0678
533 INJECTION SITE NODULE 745 0.0676
534 NEOPLASM MALIGNANT 4518 0.0676
535 BOWEL MOVEMENT IRREGULARITY 518 0.0676
536 CYTOMEGALOVIRUS INFECTION 1121 0.0674
537 DRUG-INDUCED LIVER INJURY 2110 0.0672
538 INJURY 4717 0.0670
539 DEVICE DEFECTIVE 1163 0.0670
540 NERVE INJURY 746 0.0670
541 HYPERCALCAEMIA 822 0.0665
542 POLYP 435 0.0664
543 PAPULE 468 0.0664
544 DIFFUSE LARGE B-CELL LYMPHOMA 507 0.0657
545 SKIN HAEMORRHAGE 967 0.0652
546 BONE DISORDER 1188 0.0651
547 MUSCULOSKELETAL CHEST PAIN 1008 0.0651
548 OEDEMA PERIPHERAL 7926 0.0650
549 UPPER-AIRWAY COUGH SYNDROME 535 0.0649
550 DEVICE MALFUNCTION 4552 0.0647
551 OEDEMA 3504 0.0645
552 BLOOD TEST ABNORMAL 904 0.0643
553 ABORTION SPONTANEOUS 2558 0.0638
554 EAR DISCOMFORT 655 0.0638
555 GLAUCOMA 1229 0.0638
556 ANAPHYLACTIC REACTION 3509 0.0634
557 INFLUENZA LIKE ILLNESS 5215 0.0633
558 UTERINE LEIOMYOMA 463 0.0633
559 DENTAL CARIES 700 0.0632
560 PULMONARY CONGESTION 833 0.0631
561 INTERSTITIAL LUNG DISEASE 3058 0.0631
562 CANDIDA INFECTION 1063 0.0629
563 ABASIA 1550 0.0627
564 VITAMIN D DECREASED 536 0.0626
565 FATIGUE 48762 0.0626
566 ERYTHEMA 12788 0.0621
567 HAEMORRHOIDS 1213 0.0621
568 CONCUSSION 481 0.0621
569 ABNORMAL LOSS OF WEIGHT 422 0.0618
570 TENDON RUPTURE 763 0.0617
571 HEADACHE 38651 0.0616
572 WEIGHT DECREASED 17197 0.0615
573 ENCEPHALITIS 426 0.0615
574 DEVICE DIFFICULT TO USE 4073 0.0615
575 THERAPY CESSATION 3155 0.0614
576 MUSCLE SPASTICITY 755 0.0614
577 SEASONAL ALLERGY 868 0.0613
578 ESCHERICHIA INFECTION 503 0.0611
579 HYPOKINESIA 887 0.0610
580 TRANSPLANT REJECTION 487 0.0607
581 BLOOD PRESSURE INCREASED 9276 0.0606
582 APHONIA 845 0.0605
583 RASH GENERALISED 1558 0.0601
584 DIVERTICULUM 427 0.0600
585 EYE DISORDER 1968 0.0598
586 HEAD DISCOMFORT 1059 0.0598
587 POST PROCEDURAL COMPLICATION 1141 0.0594
588 MULTIPLE ALLERGIES 464 0.0591
589 RASH PAPULAR 1325 0.0591
590 PELVIC FRACTURE 460 0.0590
591 ILLNESS 6085 0.0590
592 MUSCLE STRAIN 508 0.0587
593 TASTE DISORDER 1189 0.0585
594 SKIN DISCOLOURATION 2688 0.0584
595 PARAESTHESIA 9183 0.0583
596 PULMONARY TOXICITY 412 0.0582
597 THROAT IRRITATION 2595 0.0578
598 INTENTIONAL PRODUCT MISUSE 5043 0.0575
599 GENERALISED OEDEMA 712 0.0575
600 ORAL DISORDER 421 0.0574
601 DRY MOUTH 4652 0.0573
602 INCORRECT DOSE ADMINISTERED BY DEVICE 1496 0.0570
603 LARGE INTESTINE POLYP 393 0.0567
604 IMPAIRED QUALITY OF LIFE 815 0.0566
605 PHOTOSENSITIVITY REACTION 936 0.0566
606 CHILLS 6592 0.0562
607 PULMONARY THROMBOSIS 608 0.0557
608 THROAT TIGHTNESS 1505 0.0556
609 VITAMIN D DEFICIENCY 542 0.0555
610 LARGE INTESTINE PERFORATION 385 0.0554
611 PALLOR 1508 0.0554
612 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11171 0.0551
613 PRURITUS 21133 0.0549
614 BLOOD DISORDER 439 0.0547
615 SCAR 937 0.0547
616 LUNG NEOPLASM MALIGNANT 2249 0.0547
617 BRAIN NEOPLASM 499 0.0543
618 OSTEOPENIA 824 0.0542
619 THYROID DISORDER 835 0.0541
620 PRODUCT DOSE OMISSION 3526 0.0540
621 DIABETES MELLITUS 4111 0.0539
622 THERMAL BURN 381 0.0536
623 CONJUNCTIVITIS 995 0.0536
624 EPILEPSY 1637 0.0535
625 UROSEPSIS 494 0.0535
626 ABDOMINAL PAIN UPPER 11011 0.0534
627 CHEST DISCOMFORT 5455 0.0532
628 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3779 0.0531
629 MUSCULAR WEAKNESS 6030 0.0530
630 CARDIAC OPERATION 453 0.0526
631 DYSPEPSIA 5182 0.0526
632 FACIAL PAIN 469 0.0525
633 PRODUCT DOSE OMISSION ISSUE 15423 0.0524
634 WHITE BLOOD CELL COUNT INCREASED 2004 0.0522
635 HYPERAESTHESIA 429 0.0522
636 GALLBLADDER DISORDER 931 0.0521
637 THYROID CANCER 627 0.0520
638 LOW BIRTH WEIGHT BABY 413 0.0519
639 SPINAL COMPRESSION FRACTURE 429 0.0518
640 PAIN IN JAW 1469 0.0518
641 EMPHYSEMA 522 0.0517
642 DYSSTASIA 1510 0.0517
643 FLANK PAIN 483 0.0515
644 PHARYNGEAL OEDEMA 791 0.0514
645 RENAL CYST 408 0.0513
646 CHEST PAIN 9503 0.0513
647 SEPSIS 5692 0.0510
648 ABNORMAL FAECES 418 0.0510
649 RASH MACULAR 1774 0.0507
650 GASTRIC DISORDER 1739 0.0506
651 RIB FRACTURE 1040 0.0505
652 SPINAL FRACTURE 1011 0.0504
653 SENSORY LOSS 404 0.0501
654 BRONCHOPULMONARY ASPERGILLOSIS 387 0.0499
655 PHOTOPHOBIA 938 0.0498
656 HEPATOTOXICITY 1098 0.0493
657 ANAL INCONTINENCE 439 0.0488
658 PREMATURE BABY 1469 0.0488
659 DEAFNESS 1275 0.0487
660 LEUKAEMIA 458 0.0485
661 CARDIAC MURMUR 419 0.0484
662 DRUG DOSE OMISSION BY DEVICE 3789 0.0483
663 FRUSTRATION TOLERANCE DECREASED 390 0.0482
664 ASTHMA 5447 0.0481
665 MALNUTRITION 539 0.0481
666 OVARIAN CANCER 444 0.0481
667 PLATELET COUNT INCREASED 625 0.0479
668 HIATUS HERNIA 619 0.0478
669 FEELING COLD 1328 0.0477
670 MEMORY IMPAIRMENT 6552 0.0476
671 GASTROOESOPHAGEAL REFLUX DISEASE 3827 0.0475
672 CLOSTRIDIUM DIFFICILE COLITIS 503 0.0474
673 DERMATITIS CONTACT 540 0.0473
674 BREAST CANCER 4407 0.0472
675 PARAESTHESIA ORAL 678 0.0470
676 BURNING SENSATION 3293 0.0469
677 LABORATORY TEST ABNORMAL 1382 0.0468
678 PANCREATITIS 2468 0.0466
679 MUSCLE SPASMS 8557 0.0466
680 PREMATURE DELIVERY 742 0.0466
681 FEMUR FRACTURE 1423 0.0459
682 CHOLELITHIASIS 1505 0.0458
683 FALL 15250 0.0458
684 VAGINAL DISCHARGE 461 0.0455
685 DELIRIUM 1576 0.0454
686 ACTIVITIES OF DAILY LIVING IMPAIRED 897 0.0453
687 RESPIRATORY RATE INCREASED 402 0.0452
688 DEVICE RELATED INFECTION 693 0.0450
689 EATING DISORDER 955 0.0448
690 DRY EYE 2225 0.0445
691 ABDOMINAL DISTENSION 4652 0.0445
692 GASTRIC ULCER 837 0.0440
693 DERMATITIS 922 0.0440
694 DYSPHONIA 2557 0.0437
695 NEURALGIA 1062 0.0436
696 FEEDING DISORDER 884 0.0435
697 MOVEMENT DISORDER 1399 0.0435
698 OCULAR DISCOMFORT 489 0.0435
699 FRACTURE 824 0.0435
700 SWELLING FACE 2815 0.0432
701 BACTERAEMIA 513 0.0432
702 CONFUSIONAL STATE 6985 0.0432
703 DRY THROAT 439 0.0431
704 HIP FRACTURE 1387 0.0431
705 SKIN FISSURES 842 0.0430
706 VOMITING 20169 0.0429
707 DIARRHOEA 27646 0.0428
708 NAUSEA 33842 0.0427
709 AMNESIA 2762 0.0424
710 SEPTIC SHOCK 1842 0.0423
711 ASTHENIA 15768 0.0419
712 THERAPY PARTIAL RESPONDER 654 0.0419
713 ORAL PAIN 937 0.0418
714 PRODUCT PRESCRIBING ISSUE 907 0.0416
715 DYSPNOEA 23496 0.0415
716 EYE DISCHARGE 430 0.0413
717 GASTRITIS 1088 0.0413
718 PRESYNCOPE 1003 0.0412
719 VISUAL IMPAIRMENT 5109 0.0412
720 GOUT 737 0.0410
721 BLOOD PRESSURE ABNORMAL 813 0.0409
722 BLOOD URINE PRESENT 770 0.0405
723 PNEUMONITIS 1103 0.0405
724 INSOMNIA 10773 0.0404
725 PNEUMOTHORAX 641 0.0404
726 HYPERHIDROSIS 5207 0.0404
727 ECZEMA 2113 0.0403
728 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2208 0.0402
729 RENAL PAIN 426 0.0401
730 QUALITY OF LIFE DECREASED 539 0.0401
731 FEELING ABNORMAL 9555 0.0398
732 HEART RATE INCREASED 3944 0.0398
733 DEPRESSION 8960 0.0393
734 FLUSHING 4003 0.0393
735 COVID-19 PNEUMONIA 463 0.0392
736 HYPOACUSIS 1682 0.0390
737 EYE SWELLING 1449 0.0389
738 HOSPITALISATION 5927 0.0385
739 OCULAR HYPERAEMIA 1818 0.0383
740 ABDOMINAL PAIN LOWER 968 0.0382
741 TEMPERATURE INTOLERANCE 395 0.0382
742 INABILITY TO AFFORD MEDICATION 379 0.0381
743 NERVOUSNESS 1988 0.0380
744 SYRINGE ISSUE 664 0.0379
745 DIZZINESS 18877 0.0378
746 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 641 0.0377
747 POOR QUALITY SLEEP 811 0.0376
748 DECREASED APPETITE 8706 0.0374
749 NEUTROPHIL COUNT INCREASED 383 0.0374
750 PERIPHERAL COLDNESS 513 0.0373
751 HEPATITIS C 450 0.0372
752 EYE PAIN 2096 0.0371
753 VERTIGO 2262 0.0371
754 ALANINE AMINOTRANSFERASE INCREASED 2278 0.0371
755 COLD SWEAT 653 0.0370
756 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1926 0.0369
757 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1324 0.0364
758 MYALGIA 6194 0.0364
759 SLEEP APNOEA SYNDROME 695 0.0364
760 TACHYCARDIA 3220 0.0362
761 ACNE 2747 0.0362
762 HYPERTENSIVE CRISIS 400 0.0359
763 ANAPHYLACTIC SHOCK 924 0.0358
764 CHOLECYSTITIS 426 0.0357
765 THROMBOSIS 2864 0.0356
766 LACRIMATION INCREASED 1072 0.0354
767 RENAL DISORDER 1640 0.0352
768 DIPLOPIA 913 0.0351
769 MUSCLE TIGHTNESS 569 0.0351
770 SWOLLEN TONGUE 1097 0.0351
771 BLINDNESS 1428 0.0350
772 LEUKOPENIA 1749 0.0349
773 PLEURAL EFFUSION 2111 0.0347
774 PROCEDURAL PAIN 961 0.0346
775 OXYGEN SATURATION DECREASED 1945 0.0346
776 SPLENOMEGALY 404 0.0345
777 GINGIVAL BLEEDING 469 0.0343
778 BRONCHOSPASM 488 0.0342
779 PRODUCT USE IN UNAPPROVED INDICATION 8445 0.0340
780 DRUG PRESCRIBING ERROR 654 0.0340
781 TRANSAMINASES INCREASED 756 0.0340
782 BLOOD PRESSURE DECREASED 2257 0.0339
783 EYE HAEMORRHAGE 451 0.0338
784 BONE PAIN 1977 0.0337
785 INFUSION SITE PAIN 433 0.0336
786 TINNITUS 1542 0.0335
787 PARALYSIS 478 0.0334
788 DYSURIA 1226 0.0333
789 HYPOAESTHESIA ORAL 499 0.0331
790 LIP SWELLING 1097 0.0329
791 ORAL DISCOMFORT 455 0.0327
792 TUBULOINTERSTITIAL NEPHRITIS 612 0.0326
793 ASPARTATE AMINOTRANSFERASE INCREASED 1730 0.0325
794 DISEASE RECURRENCE 1545 0.0324
795 PALPITATIONS 3798 0.0324
796 FLUID RETENTION 1637 0.0322
797 INCORRECT DOSE ADMINISTERED 7328 0.0321
798 PRODUCT PRESCRIBING ERROR 758 0.0318
799 HAEMORRHAGE 3321 0.0317
800 HYPERSOMNIA 910 0.0317
801 POLYNEUROPATHY 380 0.0317
802 CORONARY ARTERY OCCLUSION 435 0.0317
803 PERICARDIAL EFFUSION 733 0.0317
804 HEAD INJURY 1000 0.0316
805 DEEP VEIN THROMBOSIS 2051 0.0315
806 DRUG RESISTANCE 810 0.0315
807 PULMONARY EMBOLISM 2985 0.0314
808 CYANOSIS 491 0.0312
809 HAEMATOCRIT DECREASED 619 0.0312
810 MEDICATION ERROR 1733 0.0311
811 SENSORY DISTURBANCE 500 0.0311
812 RED BLOOD CELL COUNT DECREASED 888 0.0310
813 SKIN EXFOLIATION 2620 0.0310
814 IMPAIRED GASTRIC EMPTYING 421 0.0309
815 BLOOD POTASSIUM DECREASED 923 0.0307
816 SYNCOPE 3068 0.0306
817 HOT FLUSH 2298 0.0305
818 MUSCLE ATROPHY 386 0.0304
819 BLINDNESS UNILATERAL 428 0.0303
820 LOSS OF CONSCIOUSNESS 3873 0.0302
821 NERVOUS SYSTEM DISORDER 940 0.0301
822 ANGINA PECTORIS 862 0.0301
823 DEVICE MECHANICAL ISSUE 412 0.0300
824 ACUTE RESPIRATORY DISTRESS SYNDROME 529 0.0299
825 DRUG LEVEL INCREASED 494 0.0298
826 ANXIETY 8450 0.0297
827 HAEMATEMESIS 743 0.0293
828 EPISTAXIS 2177 0.0291
829 EYE PRURITUS 974 0.0290
830 VISUAL ACUITY REDUCED 961 0.0289
831 MULTI-ORGAN FAILURE 500 0.0289
832 TRANSIENT ISCHAEMIC ATTACK 965 0.0286
833 CARDIAC DISORDER 2674 0.0286
834 FAECES DISCOLOURED 618 0.0285
835 PAIN OF SKIN 760 0.0282
836 FLATULENCE 1600 0.0282
837 DEPRESSED MOOD 1490 0.0282
838 FOETAL EXPOSURE DURING PREGNANCY 2275 0.0280
839 CRYING 1017 0.0280
840 HAEMOGLOBIN DECREASED 2847 0.0277
841 CARDIOMYOPATHY 406 0.0274
842 DISSEMINATED INTRAVASCULAR COAGULATION 386 0.0274
843 FACE OEDEMA 461 0.0273
844 POLLAKIURIA 1139 0.0273
845 RESTLESS LEGS SYNDROME 494 0.0271
846 LETHARGY 1562 0.0271
847 DEVICE USE ERROR 943 0.0271
848 MENTAL DISORDER 1179 0.0271
849 ANAEMIA 5154 0.0270
850 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 791 0.0270
851 VISION BLURRED 3682 0.0268
852 DEHYDRATION 3562 0.0267
853 HAEMATOMA 689 0.0266
854 HYPOTHYROIDISM 847 0.0265
855 EXPOSURE VIA SKIN CONTACT 687 0.0265
856 HAEMATURIA 901 0.0263
857 DEMENTIA 735 0.0263
858 DEVICE LEAKAGE 1137 0.0262
859 ATRIAL FIBRILLATION 2531 0.0260
860 PELVIC PAIN 470 0.0258
861 PRODUCT DISPENSING ERROR 563 0.0258
862 NEUROPATHY PERIPHERAL 2455 0.0258
863 MYOCARDIAL INFARCTION 4497 0.0258
864 WHITE BLOOD CELL COUNT DECREASED 2776 0.0256
865 DRUG EXPOSURE DURING PREGNANCY 868 0.0255
866 DRUG EFFECT LESS THAN EXPECTED 378 0.0255
867 ASCITES 738 0.0251
868 RETCHING 535 0.0251
869 MUSCLE TWITCHING 576 0.0250
870 DYSPNOEA EXERTIONAL 938 0.0249
871 RENAL IMPAIRMENT 2083 0.0248
872 MULTIPLE SCLEROSIS 1185 0.0248
873 PANCREATITIS ACUTE 556 0.0247
874 CEREBROVASCULAR ACCIDENT 4169 0.0246
875 PERITONITIS 502 0.0242
876 RESPIRATORY FAILURE 1750 0.0240
877 FEAR 645 0.0240
878 HYPOPHAGIA 608 0.0238
879 ARRHYTHMIA 1126 0.0238
880 TREMOR 3944 0.0237
881 CARDIOVASCULAR DISORDER 594 0.0234
882 CARDIAC FAILURE 1856 0.0231
883 MULTIPLE FRACTURES 378 0.0230
884 BALANCE DISORDER 1988 0.0230
885 TREATMENT NONCOMPLIANCE 1257 0.0230
886 RESPIRATORY DISTRESS 633 0.0229
887 METASTASES TO LIVER 403 0.0229
888 HAEMOPTYSIS 637 0.0228
889 MENORRHAGIA 447 0.0227
890 DYSPHAGIA 2149 0.0226
891 CONSTIPATION 4925 0.0226
892 HEMIPARESIS 381 0.0225
893 THERAPEUTIC RESPONSE UNEXPECTED 1002 0.0223
894 PULMONARY OEDEMA 996 0.0222
895 PANIC ATTACK 806 0.0221
896 PRODUCT ADMINISTRATION ERROR 443 0.0219
897 CARDIAC FAILURE CONGESTIVE 1760 0.0219
898 BONE DENSITY DECREASED 686 0.0219
899 HEPATIC FUNCTION ABNORMAL 809 0.0217
900 DRY SKIN 2888 0.0216
901 PROSTATE CANCER 1727 0.0214
902 BREAST CANCER FEMALE 573 0.0214
903 RENAL FAILURE 2847 0.0214
904 TOOTH LOSS 443 0.0213
905 INCREASED APPETITE 400 0.0209
906 CORONARY ARTERY DISEASE 629 0.0208
907 FEELING JITTERY 393 0.0206
908 PROTEINURIA 391 0.0205
909 URINARY INCONTINENCE 605 0.0204
910 RASH MACULO-PAPULAR 452 0.0203
911 BLOOD CREATININE INCREASED 1325 0.0203
912 HYPOTENSION 4067 0.0203
913 SPEECH DISORDER 1060 0.0202
914 PANCYTOPENIA 1121 0.0200
915 MOOD ALTERED 541 0.0198
916 CHOKING 382 0.0196
917 SOMNOLENCE 3913 0.0194
918 BLOOD ALKALINE PHOSPHATASE INCREASED 481 0.0193
919 OSTEONECROSIS 633 0.0193
920 EMOTIONAL DISORDER 591 0.0191
921 ACUTE MYOCARDIAL INFARCTION 564 0.0191
922 GAMMA-GLUTAMYLTRANSFERASE INCREASED 421 0.0190
923 MOOD SWINGS 598 0.0187
924 ALTERED STATE OF CONSCIOUSNESS 405 0.0187
925 PANCREATIC CARCINOMA 538 0.0186
926 PRODUCT DOSE OMISSION IN ERROR 527 0.0186
927 ANGIOEDEMA 819 0.0185
928 OVERDOSE 3967 0.0184
929 SHOCK 422 0.0183
930 MULTIPLE ORGAN DYSFUNCTION SYNDROME 507 0.0179
931 EXTRA DOSE ADMINISTERED 723 0.0178
932 CEREBRAL INFARCTION 436 0.0178
933 HYPOKALAEMIA 823 0.0178
934 DYSGEUSIA 1322 0.0178
935 THROMBOCYTOPENIA 1979 0.0177
936 CHROMATURIA 390 0.0173
937 COMA 817 0.0171
938 APHASIA 515 0.0170
939 HEPATIC FAILURE 501 0.0166
940 MUCOSAL INFLAMMATION 425 0.0162
941 GASTRIC CANCER 405 0.0160
942 JAUNDICE 430 0.0160
943 VAGINAL HAEMORRHAGE 683 0.0157
944 COGNITIVE DISORDER 734 0.0157
945 PLATELET COUNT DECREASED 1673 0.0157
946 SKIN IRRITATION 712 0.0155
947 EYE IRRITATION 894 0.0155
948 CONVULSION 883 0.0154
949 CEREBRAL HAEMORRHAGE 548 0.0153
950 DRUG ADMINISTRATION ERROR 464 0.0151
951 PRODUCT QUALITY ISSUE 1953 0.0144
952 CARDIO-RESPIRATORY ARREST 572 0.0137
953 BLADDER CANCER 804 0.0136
954 DISTURBANCE IN ATTENTION 724 0.0134
955 DEATH 11561 0.0134
956 GASTROINTESTINAL HAEMORRHAGE 1114 0.0133
957 BLOOD GLUCOSE DECREASED 635 0.0132
958 SEIZURE 1517 0.0131
959 IRRITABILITY 783 0.0130
960 HYPOXIA 457 0.0130
961 URINARY RETENTION 433 0.0130
962 RENAL FAILURE ACUTE 545 0.0128
963 DISORIENTATION 507 0.0128
964 INCORRECT ROUTE OF DRUG ADMINISTRATION 456 0.0127
965 SKIN BURNING SENSATION 893 0.0125
966 SUICIDAL IDEATION 1132 0.0124
967 RESTLESSNESS 449 0.0123
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 572 0.0122
969 RENAL CANCER 583 0.0122
970 DYSARTHRIA 458 0.0122
971 NIGHTMARE 415 0.0120
972 NO ADVERSE EVENT 2165 0.0119
973 NEUTROPENIA 1622 0.0119
974 ANGER 395 0.0117
975 DISEASE PROGRESSION 1320 0.0111
976 BRADYCARDIA 580 0.0109
977 BLOOD GLUCOSE INCREASED 2037 0.0108
978 CARDIAC ARREST 883 0.0107
979 DYSKINESIA 417 0.0102
980 DRUG INTERACTION 1596 0.0100
981 PRODUCT SUBSTITUTION ISSUE 565 0.0098
982 HYPOGLYCAEMIA 470 0.0097
983 ACUTE KIDNEY INJURY 1394 0.0091
984 AGITATION 665 0.0090
985 CHRONIC KIDNEY DISEASE 629 0.0083
986 HYPONATRAEMIA 463 0.0082
987 HALLUCINATION 487 0.0065
988 EMOTIONAL DISTRESS 607 0.0050
989 TOXICITY TO VARIOUS AGENTS 842 0.0050
990 DRUG DEPENDENCE 726 0.0045